Igor Koralnik to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications Igor Koralnik has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.658
-
New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab. J Neurovirol. 2005; 11 Suppl 3:52-7.
Score: 0.243
-
Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region. J Neurovirol. 2019 08; 25(4):475-479.
Score: 0.164
-
Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010 Nov; 81(11):1288-91.
Score: 0.090
-
JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol. 2005 Apr; 57(4):576-80.
Score: 0.062
-
Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol. 2003; 9 Suppl 1:25-31.
Score: 0.053
-
Recurrence of progressive multifocal leukoencephalopathy despite immune recovery in two HIV seropositive individuals. J Neurovirol. 2016 08; 22(4):541-5.
Score: 0.033
-
The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol. 2003; 9 Suppl 1:88-92.
Score: 0.013